Thursday May 23, 2019 Change -3.62% Price $1.33
Chart period: 2019-02-25 - 2019-05-23




Social Sentiment for AGRX

Today's data is from 1 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
Weighted Sentiment 0.00

Will AGRX stock price go up or down on Tue, 28 May 2019?


Agile Therapeutics Forecast and Stock Analysis

Technical AGRX stock analysis for Thursday May 23, 2019.

Sell candidate since 2019-05-22 Loss -3.62%
Shorts n/a
Insider % n/a
Institutional % 26.10%
Beta 1.63
ROA -54.01%
Price to book USD 2.45
P/E Ratio -2.63
Next Earnings Date 2019-08-14

Agile Therapeutics fell by -3.62% in the last day ( Thursday, 23rd May 2019 ) from $1.38 to $1.33 and has now fallen 3 days in a row. During day the stock fluctuated 12.50% from a day low at $1.20 to a day high of $1.35. The price has fallen in 7 of the last 10 days and is down by -7.64% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -253 916 shares and in total 301 780 shares bought and sold for approximately $401 367.00.

Quick summary:

  • 30 day high of the AGRX stock price was $1.54 and low was $1.20.
  • 90 day high was $1.70 and low was $0.90.
  • 52 week high for the Agile Therapeutics - $1.70 and low - $0.23.


Agile Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.66% during the next 3 months and, with 90% probability hold a price between $1.29 and $2.14 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Agile Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.39 and $1.45. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday May 16, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 29 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $1.14 and $1.11.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agile Therapeutics finds support just below today's level at $1.14. If this is broken, then the next support from accumulated volume will be at $1.11 and $1.07.

Support: $1.14 Price: $1.33 Resistance: $1.44


In general the stock tends to have controlled movements, but the low liquidity has increased the risk substantially.

Agile Therapeutics is oversold on RSI14 (29). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

7.55 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


The Agile Therapeutics stock holds several negative signals and despite the positive trend we believe Agile Therapeutics will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.

Sell Candidate Upgraded
Stronger Sell Today AGRX ranks #3333 as SELL CANDIDATE #3333 Weaker Sell
AGRX $1.33 ($-0.05 -3.62%)
AGRX is down $0.05 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for AGRX based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for readers.

Click here – the AGRX analysis is free »

Will AGRX stock price go up or down
on Tue, 28 May 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank